- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Best Pract Res Clin Obstet Gynaecol. 2020 Mar 7. pii: S1521-6934(20)30041-9. doi: 10.1016/j.bpobgyn.2020.02.013. [Epub ahead of print]
Assisted reproduction in hepatitis carrier couples.
Mak JSM1, Lao TT2.
Author information
1
Assisted Reproduction Technology Unit, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong. Electronic address: [email protected].
2
Department of Obstetrics & Gynaecology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong. Electronic address: [email protected].
Abstract
Chronic Hepatitis B virus (HBV) infection is endemic worldwide, and the prevalence is especially high in the Asia-Pacific regions. Despite its high prevalence, the literature regarding the impact of HBV infection on subfertility and fertility treatment remains limited and conflicting. Latest studies do not suggest any detrimental effect of HBV infection on the outcome of IVF/ICSI treatment in women having chronic HBV infection. There is evidence that HBV exists in ovarian tissue including oocyte and follicular fluid, and therefore has the potential risk of transmission to the embryo, which can explain the finding of vertical transmission despite immunoprophylaxis. Most recently, we have observed the evidence of HBV viral replication in female HBV carriers undergoing IVF/ICSI treatment. This raises the question of whether antiviral medication should be administered during ovarian stimulation in IVF/ICSI treatment cycles for women with chronic HBV infection to help reduce the chance of vertical transmission.
Copyright © 2020. Published by Elsevier Ltd.
KEYWORDS:
Follicular fluid; Hepatitis B virus Infection; In vitro fertilization; Vertical transmission; Virus replication
PMID:
32278628
DOI:
10.1016/j.bpobgyn.2020.02.013
|
|